DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to DMP. DMP was compared to 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of DMP while its profitability can be described as average. DMP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
DMP had positive earnings in the past year.
DMP had a positive operating cash flow in the past year.
In the past 5 years DMP has always been profitable.
In the past 5 years DMP always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.90%, DMP is in line with its industry, outperforming 48.08% of the companies in the same industry.
DMP has a better Return On Equity (16.22%) than 65.38% of its industry peers.
The Return On Invested Capital of DMP (7.14%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DMP is significantly below the industry average of 15.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROIC | 7.14% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin (8.74%) which is in line with its industry peers.
DMP's Profit Margin has declined in the last couple of years.
DMP has a Operating Margin of 17.82%. This is comparable to the rest of the industry: DMP outperforms 50.00% of its industry peers.
DMP's Operating Margin has improved in the last couple of years.
DMP has a Gross Margin of 64.76%. This is in the lower half of the industry: DMP underperforms 61.54% of its industry peers.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
DMP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DMP has about the same amount of shares outstanding.
DMP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.17 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
DMP has a Altman-Z score (2.17) which is comparable to the rest of the industry.
The Debt to FCF ratio of DMP is 7.58, which is on the high side as it means it would take DMP, 7.58 years of fcf income to pay off all of its debts.
DMP has a Debt to FCF ratio (7.58) which is in line with its industry peers.
DMP has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.43, DMP is doing worse than 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Altman-Z | 2.17 |
ROIC/WACC1.18
WACC6.04%
2.3 Liquidity
DMP has a Current Ratio of 2.05. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.05, DMP is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
DMP has a Quick Ratio of 2.05. This is a bad value and indicates that DMP is not financially healthy enough and could expect problems in meeting its short term obligations.
DMP has a Quick ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 83.06% over the past year.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.24%.
DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.11% on average per year.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.26, DMP is valued on the expensive side.
DMP's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.04, DMP is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.47, the valuation of DMP can be described as correct.
63.46% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
DMP is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.26 | ||
| Fwd PE | 13.47 |
4.2 Price Multiples
71.15% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 76.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.37 | ||
| EV/EBITDA | 9.31 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DMP's earnings are expected to grow with 12.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.25
PEG (5Y)2.26
EPS Next 2Y12.79%
EPS Next 3Y12.29%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.60%, DMP has a reasonable but not impressive dividend return.
DMP's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.35, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 45.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.74%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
FRA:DMP (7/25/2025, 7:00:00 PM)
35.05
-0.25 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.89B
Analysts80
Price Target46.31 (32.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP45.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.37%
PT rev (3m)-6.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.26 | ||
| Fwd PE | 13.47 | ||
| P/S | 1.59 | ||
| P/FCF | 14.37 | ||
| P/OCF | 10.94 | ||
| P/B | 2.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.31 |
EPS(TTM)1.92
EY5.48%
EPS(NY)2.6
Fwd EY7.42%
FCF(TTM)2.44
FCFY6.96%
OCF(TTM)3.2
OCFY9.14%
SpS22
BVpS11.86
TBVpS-8.21
PEG (NY)1.25
PEG (5Y)2.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROCE | 11.69% | ||
| ROIC | 7.14% | ||
| ROICexc | 7.64% | ||
| ROICexgc | 21.24% | ||
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% | ||
| FCFM | 11.08% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexcg growth 3Y-9.69%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Debt/EBITDA | 3.07 | ||
| Cap/Depr | 47.38% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 3.84 | ||
| Cash Conversion | 57.88% | ||
| Profit Quality | 126.76% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.17 |
F-Score7
WACC6.04%
ROIC/WACC1.18
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
EBIT growth 1Y28.45%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.91%
EBIT Next 3Y19.98%
EBIT Next 5Y6.79%
FCF growth 1Y-54.33%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-46.56%
OCF growth 3Y-7%
OCF growth 5Y14.89%